CVE:CZO Ceapro (CZO) Stock Price, News & Analysis → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free CZO Stock Alerts C$0.26 +0.02 (+8.33%) (As of 04/26/2024 05:33 PM ET) Add Compare Share Share Today's RangeC$0.24▼C$0.2650-Day RangeC$0.16▼C$0.2652-Week RangeC$0.15▼C$0.64Volume72,000 shsAverage Volume50,465 shsMarket CapitalizationC$20.36 millionP/E RatioN/ADividend Yield1.80%Price TargetN/A Stock AnalysisStock AnalysisChartEarningsHeadlinesStock AnalysisChartEarningsHeadlines Get Ceapro alerts: Email Address Ad Banyan Hill PublishingForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details About Ceapro Stock (CVE:CZO)Ceapro Inc., a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries. It also offers natural active ingredients, including oat powder, oat oil, oat peptides, and lupin peptides to the personal care, cosmetic, medical, and animal health industries; anti-aging skincare products to the cosmeceutical industries; and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner. The company has a research collaboration with the Angiogenesis Foundation. The company was incorporated in 1997 and is headquartered in Edmonton, Canada.Read More CZO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CZO Stock News HeadlinesMarch 12, 2024 | nz.finance.yahoo.comUniversal Music Restructuring Continues, East Coast Labels Unite via Republic Corps DivisionMarch 12, 2024 | nz.finance.yahoo.comA Complete Breakdown of Kate Middleton's Photoshop ControversyApril 28, 2024 | True Market Insiders (Ad)The “Next Bitcoin”? 10 CENT Crypto Set to ExplodeThe man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…December 14, 2023 | finance.yahoo.comCanadian Investment Regulatory Organization Trade Resumption - CZODecember 14, 2023 | finance.yahoo.comAeterna Zentaris and Ceapro Announce Merger of Equals to Create a Diversified Biopharmaceutical CompanyNovember 29, 2023 | finance.yahoo.comCeapro Inc. Reports 2023 Third Quarter and Nine-Month Financial Results and Operational HighlightsNovember 27, 2023 | nz.finance.yahoo.comPSA: Charlotte Tilbury's Mystery Box is back, and there's a huge surprise in storeNovember 27, 2023 | finance.yahoo.comCeapro Inc. Initiates Phase 1-2a Study Assessing Its Flagship Product Avenanthramides for Potential Applications in Inflammation Based DiseasesApril 28, 2024 | True Market Insiders (Ad)The “Next Bitcoin”? 10 CENT Crypto Set to ExplodeThe man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…September 14, 2023 | theglobeandmail.comClosing Bell: Ceapro Inc flat on Wednesday (CZO)September 6, 2023 | ca.finance.yahoo.comCeapro Inc. (CZO.V)August 3, 2023 | theglobeandmail.comClosing Bell: Ceapro Inc up on Wednesday (CZO)July 30, 2023 | finance.yahoo.comAre Ceapro Inc.'s (CVE:CZO) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?July 19, 2023 | theglobeandmail.comClosing Bell: Ceapro Inc down on Wednesday (CZO)May 25, 2023 | stockhouse.comCeapro Inc. Reports Financial Results for First Quarter 2023 and Provides Corporate UpdateMay 13, 2023 | theglobeandmail.comClosing Bell: Ceapro Inc up on Friday (CZO)May 3, 2023 | theglobeandmail.comClosing Bell: Ceapro Inc down on Tuesday (CZO)May 3, 2023 | finance.yahoo.comCeapro Announces Positive Findings Demonstrating Oat Derived Beta Glucan and Avenanthramides Promote Wound Healing and Tissue RegenerationApril 22, 2023 | theglobeandmail.comClosing Bell: Ceapro Inc down on Friday (CZO)April 21, 2023 | theglobeandmail.comClosing Bell: Ceapro Inc up on Thursday (CZO)April 19, 2023 | theglobeandmail.comClosing Bell: Ceapro Inc up on Tuesday (CZO)April 12, 2023 | finance.yahoo.comCeapro Inc. Reports Record 2022 Financial Results and Operational HighlightsApril 11, 2023 | theglobeandmail.comClosing Bell: Ceapro Inc down on Monday (CZO)April 6, 2023 | theglobeandmail.comClosing Bell: Ceapro Inc flat on Thursday (CZO)February 20, 2023 | finance.yahoo.comIs Weakness In Ceapro Inc. (CVE:CZO) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?November 11, 2022 | uk.finance.yahoo.comReturns At Ceapro (CVE:CZO) Are On The Way UpOctober 13, 2022 | finance.yahoo.comCeapro Inc. Announces Positive Data from Bioavailability Studies Evaluating CoQ10 Formulations Impregnated with PGX-Processed CarriersSee More Headlines Receive CZO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ceapro and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/28/2024Next Earnings (Estimated)5/23/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:CZO CUSIPN/A CIKN/A Webwww.ceapro.com Phone+1-780-4214555FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.03) Trailing P/E RatioN/A Forward P/E Ratio6.50 P/E GrowthN/ANet IncomeC$-2,810,000.00 Net Margins-24.86% Pretax MarginN/A Return on Equity-9.09% Return on Assets-6.91% Debt Debt-to-Equity Ratio7.82 Current Ratio11.00 Quick Ratio18.88 Sales & Book Value Annual SalesC$11.30 million Price / Sales1.80 Cash FlowC$0.07 per share Price / Cash Flow3.94 Book ValueC$0.38 per share Price / Book0.68Miscellaneous Outstanding Shares78,290,000Free FloatN/AMarket CapC$20.36 million OptionableNot Optionable Beta1.39 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Gilles R. Gagnon ICD.D (Age 70)M.B.A., M.Sc., CEO, President & Director Comp: $560kMs. Stacy Prefontaine C.A.CPA, CA, CPA, CFO & Corporate SecretaryDr. Bernhard SeifriedSenior Director of Research & TechnologyMr. Michel Regnier P. Eng.Senior Vice President of Technical OperationsKey CompetitorsKane BiotechCVE:KNEReunion NeuroscienceTSE:REUNSirona BiochemCVE:SBMResverlogixTSE:RVXLiberty BiopharmaCVE:LTYView All Competitors CZO Stock Analysis - Frequently Asked Questions How have CZO shares performed in 2024? Ceapro's stock was trading at C$0.19 at the beginning of the year. Since then, CZO shares have increased by 36.8% and is now trading at C$0.26. View the best growth stocks for 2024 here. When is Ceapro's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 23rd 2024. View our CZO earnings forecast. What other stocks do shareholders of Ceapro own? Based on aggregate information from My MarketBeat watchlists, some companies that other Ceapro investors own include Franco-Nevada (FNV), Badger Daylighting (BAD), FLYHT Aerospace Solutions (FLY), Invesco Water Resources ETF (PHO), Russel Metals (RUS), ServisFirst Bancshares (SFBS), Chemtrade Logistics Income Fund (CHE.UN), Bausch Health Companies (BHC), BCE (BCE) and BlackBerry (BB). How do I buy shares of Ceapro? Shares of CZO stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:CZO) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyUrgent Nvidia WarningAltimetryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ceapro Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.